EGFR overactivation may result in the resistance of tumor cells to chemotherapy and radiation treatment, via the activation of the PI3K/Akt, JAK/STAT3 and Ras/Raf/MEK/Erk downstream signaling pathways [41]. The gene discussed is AKT1; the disease is neoplasm.